clinical indications for car-t therapy in dlbcl & the possibility of moving car-t into earlier lines
Published 1 year ago • 66 plays • Length 2:42Download video MP4
Download video MP3
Similar videos
-
1:55
exploring first-line car-t therapy for the treatment of dlbcl
-
6:54
the future of car-t therapy in the management of dlbcl
-
1:06
car-t cell therapy: current applications and how to improve treatment strategies in the future
-
4:21
an insight into the changing role of transplantation for myeloma & lymphoma in the era of car-t
-
1:35
the role of car-t therapy in high-risk lbcl in the first and second-line settings
-
1:17
the impact of car-t therapy in the second-line setting in lymphoma
-
1:25
the impact of car-t therapy on patient care
-
33:15
morning medical update - car-t cell immunotherapy
-
3:33
an overview of the car t-cell therapy story
-
3:57
mechanisms and management of short- and long-term car-t toxicities
-
1:49
a novel subcutaneous car-t therapy for the treatment of hematological malignancies
-
1:29
cd5.car t-cell therapy in patients with t-cell lymphoma
-
3:05
car-t therapy in r/r dlbcl
-
1:49
car-t cell approaches in cll: current progress & future directions
-
1:33
second-line car-t therapy in b-cell lymphoma
-
2:08
an insight into the current understanding of risk factors for cll
-
0:59
the clinical implementation of car t-cell therapy
-
1:33
patient selection for car-t in all
-
2:08
the future of car t-cell therapy in lymphoma